DrugDev CEO Ibraheem Mahmood Shortlisted For 2014 SCRIP Awards

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LONDON & AUDUBON, Pa.--(BUSINESS WIRE)--DrugDev and its President and CEO Ibraheem (Ibs) Mahmood are finalists for the 10th Annual SCRIP Awards. The awards recognize innovation and excellence in the international biopharmaceutical industry. Winners chosen by a panel of luminaries from across the sector will be announced at a gala in London on 3 December.

DrugDev is a leading provider of technology-driven solutions that help investigators, sponsors and CROs do more clinical trials together. DrugDev brings together the largest online network of clinical trial sites, the leading investigator identification and start-up platform, the industry’s best trial optimization system, and the leading investigator payment capabilities to transform the way drug developers find, engage and pay doctors to run clinical trials. Learn more at www.drugdev.com

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC